Merck & Co. is a large American pharmaceutical company that develops and sells medicines and vaccines. Its recent lobbying focuses on health and drug-policy issues such as pharmacy benefit manager reform, vaccine policy, drug pricing and implementation of the Inflation Reduction Act, Medicare and Medicaid rules, trade and supply-chain policies to boost domestic manufacturing, and corporate tax matters. It has filed lobbying reports and hired The Nickles Group to represent these interests.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRETT BAKER
The latest disclosures for this client.
THE NICKLES GROUP, LLC
Q1THE NICKLES GROUP, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE NICKLES GROUP, LLC
GREG D'ANGELO
THE NICKLES GROUP, LLC
MARY BETH SAVARY TAYLOR
THE NICKLES GROUP, LLC
RACHEL JONES HENSLER
THE NICKLES GROUP, LLC
JEFF CHOUDHRY
THE NICKLES GROUP, LLC
THE NICKLES GROUP, LLC
Q3THE NICKLES GROUP, LLC
Q2THE NICKLES GROUP, LLC
Q1THE NICKLES GROUP, LLC
RA